3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Methotrexate
3
Bevacizumab
3
osimertinib
2
aumolertinib
2
Pemetrexed
2
paclitaxel-Angiopep-2 conjugate
1
nimotuzumab
1
lorlatinib
1
glutathione pegylated liposomal doxorubicin
1
eribulin
1
envafolimab
1
durvalumab
1
camrelizumab
1
aflutinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Immunoenzyme Techniques
1
Endostatins
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Meningeal Carcinomatosis
×
paclitaxel-Angiopep-2 conjugate
×
Clear all
NCT03613181
2023-04-24
ANGLeD
Angiochem Inc
Phase 3
Unknown
150 enrolled